Literature DB >> 10993288

Impaired NFAT regulation and its role in a severe combined immunodeficiency.

S Feske1, R Draeger, H H Peter, A Rao.   

Abstract

Severe Combined Immunodeficiency (SCID) is a primary immunodeficiency affecting T cells, B cells, or both. Whereas the clinical symptoms are uniformly dominated by recurrent infections, the molecular causes for SCID are very heterogeneous. Mutations in cell surface receptors, signal transduction molecules and transcription factors have been described, including the common gamma chain of the IL-2 (and IL-4, IL-7, IL-9 and IL-15) receptors, the kinase JAK-3, the epsilon and gamma chains of CD3, the protein tyrosine kinase ZAP-70, as well as CIITA and RFX5 involved in MHC class II gene expression. In this work we describe two infants with SCID whose T cells display a severe defect in T cell activation and cytokine transcription due to impaired activation of the transcription factor NFAT. We show that this defect in activation is not due to mutations in the NFAT proteins expressed in T cells or the phosphatase calcineurin which regulates the activation of NFAT. However, nuclear import of NFAT in response to T cell activation was severely compromised in the patients' T cells. A modest degree of nuclear translocation of NFAT was achieved in the patients' T cells when nuclear export was inhibited using lithium chloride. This low level of nuclear NFAT in the nucleus was not sufficient to compensate for the defect in cytokine production in the patients' T cells. However, elevated levels of extracellular calcium led to an increase in cytokine gene transcription by the SCID T cells, suggesting that the underlying genetic defect in the patients involved calcium influx or the initiation of calcium signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993288     DOI: 10.1016/S0171-2985(00)80060-1

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  TRPC3 channels confer cellular memory of recent neuromuscular activity.

Authors:  Paul Rosenberg; April Hawkins; Jonathan Stiber; John M Shelton; Kelley Hutcheson; Rhonda Bassel-Duby; Dong Min Shin; Zhen Yan; R Sanders Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

Review 2.  Pharmacology of store-operated calcium channels.

Authors:  James W Putney
Journal:  Mol Interv       Date:  2010-08

3.  Inhibition of breast cancer cell proliferation through disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 4.  The functions of store-operated calcium channels.

Authors:  James W Putney; Natacha Steinckwich-Besançon; Takuro Numaga-Tomita; Felicity M Davis; Pooja N Desai; Diane M D'Agostin; Shilan Wu; Gary S Bird
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-11-30       Impact factor: 4.739

Review 5.  STIM proteins: integrators of signalling pathways in development, differentiation and disease.

Authors:  Lorna S Johnstone; Sarah J L Graham; Marie A Dziadek
Journal:  J Cell Mol Med       Date:  2010-06-17       Impact factor: 5.310

6.  STIM1-mediated calcium influx controls antifungal immunity and the metabolic function of non-pathogenic Th17 cells.

Authors:  Sascha Kahlfuss; Ulrike Kaufmann; Axel R Concepcion; Lucile Noyer; Dimitrius Raphael; Martin Vaeth; Jun Yang; Priya Pancholi; Mate Maus; James Muller; Lina Kozhaya; Alireza Khodadadi-Jamayran; Zhengxi Sun; Patrick Shaw; Derya Unutmaz; Peter B Stathopulos; Cori Feist; Scott B Cameron; Stuart E Turvey; Stefan Feske
Journal:  EMBO Mol Med       Date:  2020-07-01       Impact factor: 12.137

7.  Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo.

Authors:  Jayati Mookerjee-Basu; Robert Hooper; Scott Gross; Bryant Schultz; Christina K Go; Elsie Samakai; Jonathan Ladner; Emmanuelle Nicolas; Yuanyuan Tian; Bo Zhou; M Raza Zaidi; Warren Tourtellotte; Shan He; Yi Zhang; Dietmar J Kappes; Jonathan Soboloff
Journal:  EMBO Rep       Date:  2020-03-25       Impact factor: 8.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.